Results 51 to 60 of about 31,995 (218)

B Cell Subsets and Atherosclerosis: Updates and Emerging Concepts

Immunological Reviews, Volume 339, Issue 1, May 2026.
ABSTRACT Atherosclerotic cardiovascular disease (ASCVD) is increasingly recognized not just as a lipid‐driven disease, but as a complex interplay between vascular cells and the immune system. Accumulating evidence highlights a central, yet heterogeneous role for B cells in atherogenesis, with distinct subsets displaying opposing roles.
Sophieke Lems, Megan Grace Mazzei, Amanda C. Foks, Coleen A. McNamara   +3 more
wiley   +1 more source

Setting priorities for development of emerging interventions against childhood pneumonia, meningitis and influenza [PDF]

, 2012
WAcute lower respiratory infections, which broadly include pneumonia and bronchiolitis, are still the leading cause of childhood mortality. ALRI contributed to 18% of all deaths in children younger than five years of age in 2008, and the main pathogens ...
Black, Catto, Choudhuri, George, Graham, Higginson, Horwood, Huda, Lawn, Nair, Nair, Nair, O'Brien, Osterholt, Rudan, Rudan, Rudan, Rudan, Rudan, Tomlinson, Watt, Webster   +21 more
core   +3 more sources

Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin [PDF]

, 2020
Streptococcus pneumoniae serotype 1 is the predominant cause of invasive pneumococcal disease in sub-Saharan Africa, but the mechanism behind its increased invasiveness is not well understood.
Baltazar, Murielle, Bricio-Moreno, Laura, Dowson, Christopher G., Everett, Dean B., Jacques, Laura C., Kadioglu, Aras, Khandaker, Shadia, Neill, Daniel R., Panagiotou, Stavros, Senghore, Madikay, Xu, Rong, Yang, Marie   +11 more
core   +4 more sources

Outbreak of Serotype 1 Invasive Pneumococcal Disease, Kibera Urban Informal Settlement, Nairobi, Kenya, 2023

Emerging Infectious Diseases
Use of 10-valent pneumococcal conjugate vaccine in Kenya has led to substantial reductions in vaccine-type pneumococcal carriage and invasive pneumococcal disease.
Terry Komo, Patrick K. Munywoki, Maria da Gloria Carvalho, Joshua Auko, Alice Ouma, Allan Audi, George O. Agogo, Daniel Omondi, Arthur Odoyo, Herine Odiembo, Newton Wamola, Mike Osita, Clayton Onyango, Naomi Lucchi, Peninah Munyua, Amy Herman-Roloff, Shanda Larson, Sopio Chochua, Fabiana C. Pimenta, Godfrey Bigogo, Jennifer R. Verani   +20 more
doaj   +1 more source

Childhood meningitis in Kuwait in the era of post pneumococcal conjugate vaccination: A multicenter study

Journal of Infection and Public Health, 2017
This is a retrospective study to evaluate epidemiology and etiologies of childhood meningitis in Kuwait after the routine introduction of the pneumococcal conjugate vaccine. The data was collected from 196 patients in the period of 2010–2014.
Hussain Sadeq, Entesar H. Husain, Amna Alkoot, Suha Atyani, Abdullah Al-fraij, Abdulrahman Al-Daithan, Talal AlSaleem, Anfal Taher, May Alenezi   +8 more
doaj   +1 more source

Vaccination in Kidney Transplant Candidates

Transplantation Direct, 2023
Background:. Kidney transplant (KT) candidates have historically low immunization rates against recommended vaccines. A retrospective single-center study of contemporary KT candidates was conducted to assess vaccination rates and vaccine uptake. Methods:.
Kiran Gajurel, MD, Tue Ngo, MD, MPH, Robert T. Fairman, PhD, MPH, Lewis H. McCurdy, MD   +3 more
doaj   +1 more source

Burden of Influenza and Cost‐Effectiveness Analysis of Introduction of an Influenza Vaccination Programme Among Older Adults in India

Influenza and Other Respiratory Viruses, Volume 20, Issue 5, May 2026.
ABSTRACT Background In India, no publicly funded seasonal influenza immunization is ongoing, partly because cost‐effectiveness is yet to be established. We estimate the cost‐effectiveness and budgetary impact of introducing seasonal influenza vaccination among adults aged ≥ 60 years in India, a known high‐risk group. Methods Estimates of disease burden
Anand Krishnan, Aslesh Ottapura Prabhakaran, Kusum Shekhawat, Ismael R. Ortega‐Sanchez, Rakesh Kumar, Ritvik Amarchand, Prabu Rajkumar, Suman Kanungo, Sumit Dutt Bhardwaj, Giridara Gopal, Girish Kumar Chethrapilly Purushothaman, Varsha Potdar, Alok Kumar Chakrabarti, Radhika Gharpure, Avinash Choudekar, Kathryn E. Lafond, Lalit Dar, Siddhartha Saha, Kathrine R. Tan, Eduardo Azziz‐Baumgartner   +19 more
wiley   +1 more source

Prevalence, spatial distribution and determinants of complete childhood pneumococcal conjugate vaccination in Ethiopia: spatial and multilevel analyses

BMC Public Health
Introduction Pneumococcal disease is a serious global public health concern. The primary causative agent of severe illnesses such as pneumonia, meningitis, acute otitis media, and bacteremia is the pneumococcus bacterium.
Tadesse Tarik Tamir, Bewuketu Terefe, Mulugeta Wassie, Belayneh Shetie Workneh, Alebachew Ferede Zegeye   +4 more
doaj   +1 more source

Age at First RSV Hospitalisation and the Risk of Subsequent Bacterial Pneumonia

Acta Paediatrica, EarlyView.
Samuel Videholm, Karin Strandell, Maria Björmsjö, Andreas Tornevi, Sven Arne Silfverdal   +4 more
wiley   +1 more source

Hepatitis B Virus, Pneumococcal, Diphtheria, and Tetanus Vaccination Responses in Compensated Cirrhosis

Liver International, Volume 46, Issue 5, May 2026.
ABSTRACT Background and Aims Cirrhosis favours infections that can lead to liver decompensation and death. Some of these infections can be prevented by vaccination. This study aimed to evaluate the immune response after HBV, pneumococcal, diphtheria, and tetanus vaccination in cirrhotic patients.
Vincent Haghnejad, Mélissa Lucas, Lucie Chevrier, Hélène Jeulin, Isabela Quilici, Sébastien Daude, Mouni Bensenane‐Oussalah, Nicolas Jacquinot, Evelyne Schvoerer, Frederic Batteux, Jean Pierre Bronowicki   +10 more
wiley   +1 more source